Literature DB >> 19753481

Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy.

Edecio Cunha-Neto1, Luciana G Nogueira, Priscila C Teixeira, Rajendranath Ramasawmy, Sandra A Drigo, Anna Carla Goldberg, Simone G Fonseca, Angelina M Bilate, Jorge Kalil.   

Abstract

The pathogenesis of Chagas disease cardiomyopathy (CCC) is not well understood. Since studies show that myocarditis is more frequent during the advanced stages of the disease, and the prognosis of CCC is worse than that of other dilated cardiomyopathies of non-inflammatory aetiology, which suggest that the inflammatory infiltrate plays a major role in myocardial damage. In the last decade, increasing evidence has shown that inflammatory cytokines and chemokines play a role in the generation of the inflammatory infiltrate and tissue damage. CCC patients have an increased peripheral production of the inflammatory Th1 cytokines IFN-gamma and TNF-alpha when compared to patients with the asymptomatic/indeterminate form. Moreover, Th1-T cells are the main producers of IFN-gamma and TNF-alpha and are frequently found in CCC myocardial inflammatory infiltrate. Over the past several years, our group has collected evidence that shows several cytokines and chemokines produced in the CCC myocardium may also have a non-immunological pathogenic effect via modulation of gene and protein expression in cardiomyocytes and other myocardial cell types. Furthermore, genetic polymorphisms of cytokine, chemokine and innate immune response genes have been associated with disease progression. We will review the molecular and immunological mechanisms of myocardial damage in human CCC in light of recent findings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19753481     DOI: 10.1590/s0074-02762009000900032

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  38 in total

1.  Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease.

Authors:  S M Keating; X Deng; F Fernandes; E Cunha-Neto; A L Ribeiro; B Adesina; A I Beyer; P Contestable; B Custer; M P Busch; E C Sabino
Journal:  Int J Cardiol       Date:  2015-07-12       Impact factor: 4.164

Review 2.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  MicroRNA-155 Deficiency Exacerbates Trypanosoma cruzi Infection.

Authors:  Bijay K Jha; Sanjay Varikuti; Abhay R Satoskar; Bradford S McGwire; Gabriella R Seidler; Greta Volpedo
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

4.  Low doses of simvastatin therapy ameliorate cardiac inflammatory remodeling in Trypanosoma cruzi-infected dogs.

Authors:  Lilian Melo; Ivo Santana Caldas; Maíra Araújo Azevedo; Karolina Ribeiro Gonçalves; Alvaro Fernando da Silva do Nascimento; Vivian Paulino Figueiredo; Lívia de Figueiredo Diniz; Wanderson Geraldo de Lima; Rosália Moraes Torres; Maria Terezinha Bahia; André Talvani
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

5.  Sequence variation in the IL4 gene and resistance to Trypanosoma cruzi infection in Bolivians.

Authors:  Lucia Elena Alvarado Arnez; Evaristo N Venegas; Carole Ober; Emma E Thompson
Journal:  J Allergy Clin Immunol       Date:  2011-01       Impact factor: 10.793

Review 6.  Modulation of immune response in experimental Chagas disease.

Authors:  Beatriz Basso
Journal:  World J Exp Med       Date:  2013-02-20

Review 7.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

8.  Molecular imaging, biodistribution and efficacy of mesenchymal bone marrow cell therapy in a mouse model of Chagas disease.

Authors:  Antonio C Campos de Carvalho; David C Spray; Linda A Jelicks; Herbert B Tanowitz; Vera Maria Peters; Rosalia Mendez-Otero
Journal:  Microbes Infect       Date:  2014-09-16       Impact factor: 2.700

Review 9.  Interferon-γ and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy.

Authors:  Ludmila Rodrigues Pinto Ferreira; Amanda Farage Frade; Monique Andrade Baron; Isabela Cunha Navarro; Jorge Kalil; Christophe Chevillard; Edecio Cunha-Neto
Journal:  World J Cardiol       Date:  2014-08-26

10.  Trypanosoma cruzi SSP4 Amastigote Protein Induces Expression of Immunoregulatory and Immunosuppressive Molecules in Peripheral Blood Mononuclear Cells.

Authors:  Yadira Morán-Utrera; Aracely López-Monteon; José Luis Rosales-Encina; Enrique Méndez-Bolaina; Angel Ramos-Ligonio
Journal:  J Trop Med       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.